Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Clovis Oncology, Inc. | clvs-20171231ex3222b5bda.htm |
| EX-32.1 - EX-32.1 - Clovis Oncology, Inc. | clvs-20171231ex32156c0fa.htm |
| EX-31.2 - EX-31.2 - Clovis Oncology, Inc. | clvs-20171231ex3126aa7a0.htm |
| EX-31.1 - EX-31.1 - Clovis Oncology, Inc. | clvs-20171231ex3111fe53e.htm |
| EX-23.1 - EX-23.1 - Clovis Oncology, Inc. | clvs-20171231ex231509864.htm |
| 10-K - 10-K - Clovis Oncology, Inc. | clvs-20171231x10k.htm |
Exhibit 12.1
Clovis Oncology, Inc.
Computation of Deficiency of Earnings to Fixed Charges
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended December 31, |
|
||||||||||||||||||
|
|
|
2017 |
|
|
2016 |
|
|
2015 |
|
|
2014 |
|
|
2013 |
|
||||||
|
|
|
|
|||||||||||||||||||
|
Earnings (loss): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
$ |
(349,975) |
|
|
$ |
(381,171) |
|
|
$ |
(381,937) |
|
|
$ |
(157,723) |
|
|
$ |
(84,480) |
|
|
|
Fixed charges (from below) |
|
|
10,988 |
|
|
|
9,119 |
|
|
|
8,824 |
|
|
|
2,698 |
|
|
|
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total loss |
|
$ |
(338,987) |
|
|
$ |
(372,052) |
|
|
$ |
(373,113) |
|
|
$ |
(155,025) |
|
|
$ |
(84,395) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed charges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
$ |
9,148 |
|
|
$ |
7,249 |
|
|
$ |
7,167 |
|
|
$ |
2,236 |
|
|
$ |
— |
|
|
|
Amortization of debt issuance costs |
|
|
1,279 |
|
|
|
1,242 |
|
|
|
1,205 |
|
|
|
368 |
|
|
|
— |
|
|
|
Interest portion of rent expense |
|
|
561 |
|
|
|
628 |
|
|
|
452 |
|
|
|
94 |
|
|
|
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed charges |
|
$ |
10,988 |
|
|
$ |
9,119 |
|
|
$ |
8,824 |
|
|
$ |
2,698 |
|
|
$ |
85 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Coverage deficiency |
|
$ |
349,975 |
|
|
$ |
381,171 |
|
|
$ |
381,937 |
|
|
$ |
157,723 |
|
|
$ |
84,480 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|